Efficacy and acceptability of mobile application-delivered acceptance and commitment therapy for posttraumatic stress disorder in China: A randomized controlled trial

被引:6
|
作者
Zhao, Chunxiao [1 ]
Zhao, Ziyi [2 ]
Levin, Michael E. [3 ]
Lai, Lizu [2 ]
Shi, Congrong [2 ]
Hu, Jiawei [2 ]
Chen, Wenke [2 ]
Ren, Zhihong [2 ,4 ]
机构
[1] Hubei Univ Chinese Med, Sch Humanities, 16 Huangjiahu West Rd, Wuhan, Hubei, Peoples R China
[2] Cent China Normal Univ, Key Lab Adolescent Cyberpsychol & Behav CCNU, Key Lab Human Dev & Mental Hlth Hubei Prov, Sch Psychol,Minist Educ, 382 Xiongchu Ave,Luonan St, Wuhan, Hubei, Peoples R China
[3] Utah State Univ, Dept Psychol, 2810 Old Main Hill, Logan, UT 84322 USA
[4] 382 Xiongchu Ave,Luonan St, Wuhan, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
Posttraumatic stress disorder; Randomized controlled trial; ACT; China; Mobile app-delivered intervention; DEPRESSIVE SYMPTOMS; ANXIETY DISORDER; PANIC DISORDER; MENTAL-HEALTH; PTSD; METAANALYSIS; INTERVENTION; INTERNET; DROPOUT; PSYCHOTHERAPY;
D O I
10.1016/j.brat.2023.104440
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Due to the COVID-19 pandemic and its extensive effects, the incidence of posttraumatic stress disorder (PTSD) symptoms is rapidly increasing in China. This research aimed to assess the efficacy and acceptability of a mobile application delivering Acceptance and Commitment Therapy (ACT) in reducing PTSD symptoms. 221 Chinese individuals with elevated PTSD symptoms were randomly assigned to app-delivered ACT (ACT condition), appdelivered mindfulness (MI condition), or a waitlist (WL condition). Assessments were performed pre- and postintervention. The results showed that participants in both the ACT and MI groups had significantly greater improvements across mental health outcomes compared to the WL group. No significant differences were observed between the ACT and MI groups except for psychological flexibility, which improved more in ACT than MI (d = -0.37). Compared to WL, the ACT group showed a greater improvement in PTSD symptoms (d = -0.79), anxiety (d = -0.62), depression (d = -0.51), posttraumatic growth (d = 0.46), and psychological flexibility (d = 0.76). The drop-out rates in the ACT and MI were 25.76% and 39.71%, respectively. Participants in the ACT condition reported medium program satisfaction. The study suggests app-delivered ACT is efficacious in reducing PTSD symptoms and improving overall mental health among Chinese adults.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] A randomized controlled trial of ganaxolone in posttraumatic stress disorder
    Rasmusson, Ann M.
    Marx, Christine E.
    Jain, Sonia
    Farfel, Gail M.
    Tsai, Julia
    Sun, Xiaoying
    Geracioti, Thomas D.
    Hamner, Mark B.
    Lohr, James
    Rosse, Richard
    Summerall, Lanier
    Naylor, Jennifer C.
    Cusin, Cristine
    Lang, Ariel J.
    Raman, Rema
    Stein, Murray B.
    PSYCHOPHARMACOLOGY, 2017, 234 (15) : 2245 - 2257
  • [22] Pilot Randomized Controlled Trial of Web-Delivered Acceptance and Commitment Therapy Versus Smokefree.gov for Smokers With Bipolar Disorder
    Heffner, Jaimee L.
    Kelly, Megan M.
    Waxmonsky, Jeanette
    Mattocks, Kristin
    Serfozo, Edit
    Bricker, Jonathan B.
    Mull, Kristin E.
    Watson, Noreen L.
    Ostacher, Michael
    NICOTINE & TOBACCO RESEARCH, 2020, 22 (09) : 1543 - 1552
  • [23] Randomized Controlled Trial of a Smartphone Application as an Adjunct to Acceptance and Commitment Therapy for Smoking Cessation
    O'Connor, Martin
    Whelan, Robert
    Bricker, Jonathan
    McHugh, Louise
    BEHAVIOR THERAPY, 2020, 51 (01) : 162 - 177
  • [24] Randomized Controlled Trial of Online Acceptance and Commitment Therapy for Fibromyalgia
    Simister, Heather D.
    Tkachuk, Gregg A.
    Shay, Barbara L.
    Vincent, Norah
    Pear, Joseph J.
    Skrabek, Ryan Q.
    JOURNAL OF PAIN, 2018, 19 (07): : 741 - 753
  • [25] A randomized controlled trial of acceptance and commitment therapy for clinical perfectionism
    Ong, Clarissa W.
    Lee, Eric B.
    Krafft, Jennifer
    Terry, Carina L.
    Barrett, Tyson S.
    Levin, Michael E.
    Twohig, Michael P.
    JOURNAL OF OBSESSIVE-COMPULSIVE AND RELATED DISORDERS, 2019, 22
  • [26] EVALUATING ACCEPTANCE AND COMMITMENT THERAPY FOR INSOMNIA: A RANDOMIZED CONTROLLED TRIAL
    Baik, Kyoung
    Lang, Brent A.
    Walter, Jessica B.
    Baker, Cassandra J.
    Awada, Samantha
    O'Brien, William H.
    ANNALS OF BEHAVIORAL MEDICINE, 2016, 50 : S65 - S65
  • [27] A Randomized Controlled Trial of Acceptance and Commitment Therapy for Aggressive Behavior
    Zarling, Amie
    Lawrence, Erika
    Marchman, James
    JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2015, 83 (01) : 199 - 212
  • [28] Efficacy and Safety of Balovaptan for Posttraumatic Stress Disorder: A Randomized, Placebo-Controlled Trial
    Marler, Sarah
    Rabbia, Michael
    Sanders, Kevin
    Derks, Michael
    Bailey, Lorna
    Vilimovskij, Alexandr
    Maurer, Joerg
    Nordstroem, Anna-Lena
    Guthrie, Heather
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2025, 33 (01) : 43 - 52
  • [29] Efficacy of Quetiapine Monotherapy in Posttraumatic Stress Disorder: A Randomized, Placebo-Controlled Trial
    Villarreal, Gerardo
    Hamner, Mark B.
    Canive, Jose M.
    Robert, Sophie
    Calais, Lawrence A.
    Durklaski, Valerie
    Zhai, Yusheng
    Qualls, Clifford
    AMERICAN JOURNAL OF PSYCHIATRY, 2016, 173 (12): : 1205 - 1212
  • [30] Efficacy of Vortioxetine Monotherapy for Posttraumatic Stress Disorder A Randomized, Placebo-Controlled Trial
    Dunlop, Boadie W.
    Rakofsky, Jeffrey J.
    Newport, D. Jeffrey
    Mletzko-Crowe, Tanja
    Barone, Katelyn
    Nemeroff, Charles B.
    Harvey, Philip D.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2021, 41 (02) : 172 - 179